Department of Craniomaxillofacial Surgery, Maastricht University Medical Center, Maastricht, the Netherlands; GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.
Department of Craniomaxillofacial Surgery, Maastricht University Medical Center, Maastricht, the Netherlands.
Int J Oral Maxillofac Surg. 2022 Jan;51(1):122-132. doi: 10.1016/j.ijom.2021.03.016. Epub 2021 Apr 10.
The aim of this systematic review and meta-analysis was to critically evaluate the currently existing clinical evidence on the efficacy of graftless maxillary sinus membrane elevation for implantation in the atrophic posterior maxilla. A search protocol without limitations to November 2020 was followed by two independent researchers. Randomized controlled trials using the lateral window approach for graftless sinus membrane elevation were included. Uncontrolled, retrospective, non-comparative studies, case reports, and experimental studies in animals or cadavers were excluded. The search identified 2777 studies. Critical selection by two independent researchers then led to the inclusion of a total of nine studies. A risk of bias assessment was applied using the revised Cochrane risk-of-bias tool for randomized trials. A meta-analysis was conducted for seven studies. Results showed a high overall implant survival rate in both the graftless and bone-grafted sinus lift groups (97.92% and 98.73%, respectively). The graftless sinus lift group showed a significantly lower vertical bone height gain, with a mean difference of -1.73mm (P=0.01), and a significantly lower bone density, with a mean difference of -94.7 HU (P<0.001). The implant stability quotient values did not differ significantly between the test and control groups (P=0.07).
本系统评价和荟萃分析的目的是批判性地评估目前关于无植骨上颌窦膜提升术用于治疗后牙区萎缩性上颌骨的临床疗效的现有证据。研究人员遵循了一项无限制检索至 2020 年 11 月的检索方案。研究人员纳入了使用外侧壁开窗法进行无植骨窦膜提升术的随机对照试验。未使用对照、回顾性、非对照研究、病例报告和动物或尸体实验研究被排除在外。检索共确定了 2777 项研究。随后,两名独立研究人员进行了严格的选择,最终纳入了总共 9 项研究。使用修订后的 Cochrane 随机试验偏倚风险评估工具对这些研究进行了偏倚风险评估。对 7 项研究进行了荟萃分析。结果显示,无植骨和植骨上颌窦提升组的总体种植体存活率均较高(分别为 97.92%和 98.73%)。无植骨上颌窦提升组的垂直骨高度增加明显较低,平均差异为-1.73mm(P=0.01),且骨密度明显较低,平均差异为-94.7 HU(P<0.001)。两组间的种植体稳定性指数值无显著差异(P=0.07)。